Finally, five little-characterized hub genes, AP3B2, GABRD, GPR158, KIAA0513, and MAL2, were chosen to test their expression levels in different Braak stages, their diagnostic values for AD and mild cognitive impairment (MCI), and their correlations with β-secretase activity and Aβ42 levels. This evidence concerns the gene KIAA0513 and Alzheimer disease.